Fugmann T - Search Results

1

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer.

Trincado JL, Reixachs-Solé M, Pérez-Granado J, Fugmann T, Sanz F, Yokota J, Eyras E. Trincado JL, et al. Among authors: fugmann t. PLoS Comput Biol. 2021 Sep 16;17(9):e1009411. doi: 10.1371/journal.pcbi.1009411. eCollection 2021 Sep. PLoS Comput Biol. 2021. PMID: 34529669 Free PMC article.

2

Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.

Gloger A, Ritz D, Fugmann T, Neri D. Gloger A, et al. Among authors: fugmann t. Cancer Immunol Immunother. 2016 Nov;65(11):1377-1393. doi: 10.1007/s00262-016-1897-3. Epub 2016 Sep 6. Cancer Immunol Immunother. 2016. PMID: 27600516 Free PMC article.

3

Intron retention is a source of neoepitopes in cancer.

Smart AC, Margolis CA, Pimentel H, He MX, Miao D, Adeegbe D, Fugmann T, Wong KK, Van Allen EM. Smart AC, et al. Among authors: fugmann t. Nat Biotechnol. 2018 Dec;36(11):1056-1058. doi: 10.1038/nbt.4239. Epub 2018 Aug 16. Nat Biotechnol. 2018. PMID: 30114007 Free PMC article.

4

High-resolution analysis of the murine MHC class II immunopeptidome.

Sofron A, Ritz D, Neri D, Fugmann T. Sofron A, et al. Among authors: fugmann t. Eur J Immunol. 2016 Feb;46(2):319-28. doi: 10.1002/eji.201545930. Epub 2015 Nov 17. Eur J Immunol. 2016. PMID: 26495903 Free article.

5

Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery.

Ritz D, Gloger A, Neri D, Fugmann T. Ritz D, et al. Among authors: fugmann t. Proteomics. 2017 Jan;17(1-2):10.1002/pmic.201600364. doi: 10.1002/pmic.201600364. Epub 2016 Dec 22. Proteomics. 2017. PMID: 27862975 Free PMC article.

6

Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform.

Ritz D, Kinzi J, Neri D, Fugmann T. Ritz D, et al. Among authors: fugmann t. Proteomics. 2017 Oct;17(19):10.1002/pmic.201700177. doi: 10.1002/pmic.201700177. Proteomics. 2017. PMID: 28834231 Free PMC article.

7

The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Fugmann T, Sofron A, Ritz D, Bootz F, Neri D. Fugmann T, et al. J Immunol. 2017 Feb 1;198(3):1357-1364. doi: 10.4049/jimmunol.1601157. Epub 2016 Dec 23. J Immunol. 2017. PMID: 28011936 Free PMC article.

8

Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice.

Ziffels B, Stringhini M, Probst P, Fugmann T, Sturm T, Neri D. Ziffels B, et al. Among authors: fugmann t. Mol Cancer Ther. 2019 Sep;18(9):1544-1554. doi: 10.1158/1535-7163.MCT-18-1301. Epub 2019 Jun 18. Mol Cancer Ther. 2019. PMID: 31213507 Free PMC article.

9

High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

Ritz D, Gloger A, Weide B, Garbe C, Neri D, Fugmann T. Ritz D, et al. Among authors: fugmann t. Proteomics. 2016 May;16(10):1570-80. doi: 10.1002/pmic.201500445. Proteomics. 2016. PMID: 26992070 Free PMC article.

10

Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine.

Probst P, Stringhini M, Ritz D, Fugmann T, Neri D. Probst P, et al. Among authors: fugmann t. Clin Cancer Res. 2019 Jan 15;25(2):698-709. doi: 10.1158/1078-0432.CCR-18-1728. Epub 2018 Oct 16. Clin Cancer Res. 2019. PMID: 30327303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page